1. Articles from Yang C , et al.

    1-1 of 1
    1. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma.

      YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma.

      Oncotarget. 2017 Mar 15;:

      Authors: Yang C, Tan J, Zhu J, Wang S, Wei G

      Abstract The transcriptional co-activator Yes-associated protein (YAP) is essential for Hippo pathway-driven tumorigenesis in various cancers. However, the expression and function of YAP in neuroblastoma remains elusive. Here, we show that YAP was highly expressed in Neuroblastoma (NB) and expression levels correlated with advanced tumor staging.

      Read Full Article
    1-1 of 1
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Topics in the News

    1. (1 articles) Tumorigenesis
    2. (1 articles) Staging
  3. Popular Articles

  4. Picture Gallery

    MRI without contrast agents? Yes, with sugar! New Biomarker Assay Detects Neuroblastoma with Greater Sensitivity Presence of protein important clue to tumour regression in neuroblastoma New biomarker assay detects neuroblastoma with greater sensitivity New research points to potential targeted treatments of neuroblastoma tumours Combining immunotherapies effective against mouse model of cancer Screening Recommendations for Children with Common Cancer Predisposition Syndromes New research points to potential for more targeted treatments of neuroblastoma tumors Telomere study improves understanding of cellular aging and cancer development Giving children a voice in clinical trials NCI-MATCH cancer trial reaches 6,000-patient tumor sequencing goal 2 years early CVD Risk Factors Identified in Long-Term Survivors of Pediatric Cancer